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a b s t r a c t
Insulin-like growth factor (IGF-I) is hypothesized to be a critical upstream regulator of mammalian
target of rapamycin (mTOR)-regulated protein synthesis with muscle contraction. We utilized a
mouse model that expresses a skeletal muscle speciﬁc dominant-negative IGF-I receptor to investigate the role of IGF-I signaling of protein synthesis in response to unilateral lengthening contractions (10 sets, 6 repetitions, 100 Hz) at 0 and 3 h following the stimulus. Our results indicate that
one session of high frequency muscle contractions can activate mTOR signaling independent of signaling components directly downstream of the receptor.
Ó 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

1. Introduction
The initial phases of skeletal muscle hypertrophy are characterized by signiﬁcant increases in protein synthesis rates followed by
increases in total protein content that are not matched by changes
in total RNA content [1]. This suggests that during the initial
phases of mechanical loading of the muscle, mechanisms that regulate protein synthesis are critical for induction of muscle hypertrophy. It is still largely unclear how a load stimulus is converted
into the activation of signaling pathways that enhance muscle
mass. Recent evidence has suggested that the mammalian target
of rapamycin (mTOR) signaling pathway is a critical component
for muscle to translate increased load into growth, but the means
by which load activates mTOR signaling has remained elusive.
The most common hypothesis is that mechanical load of muscle increases autocrine/paracrine production of insulin-like growth factor-I (IGF-I) expression, which leads to phosphatidylinosoltol 3
kinase (PI3K) and phosphatidylinosoltol regulated protein kinase
(Akt) mediated activation of mTOR. p70S6k phosphorylation at
threonine residue 389 is a direct substrate of mTOR signaling,
Abbreviations: Akt, phosphatidylinosoltol regulated protein kinase; IGF-I, insulin-like growth factor-I; IOD, integrated optical densities; IRS-1, insulin related
substrate-1; MKR, IGF-I receptor mutant mouse; mTOR, mammalian target of
rapamycin; PI3K, phosphatidylinosoltol 3 kinase; PRAS40, proline-rich Akt substrate 40; TA, tibialis anterior; WT, wild-type
* Corresponding author. Fax: +1 301 405 5578.
E-mail addresses: switkows@umd.edu, espen@umd.edu (E.E. Spangenburg).

and thus is regarded as an indicator of active mTOR [2,3]. This
has similarly been shown in muscle as the change in p70S6k (Thr389) with mechanical load is inhibited with rapamycin (mTOR
inhibitor) treatment [4]. Genetic ablation of p70S6k resulted in signiﬁcantly decreased muscle ﬁber size that was similar to decreases
with inhibition of mTOR via rapamycin [5], indicating that p70S6k is
indeed important for muscle hypertrophy. Thus, ablation of downstream signaling substrates of mTOR leads to inhibition of mechanical load-induced muscle hypertrophy.
IGF-I has been proposed as a mechanism by which mechanical
load (i.e. resistance exercise) activates muscle protein synthesis via
the PI3K/Akt/mTOR/p70S6k pathway. This hypothesis is based on
the fact that skeletal muscle IGF-I expression is increased with
mechanical load [6] and that exogenous IGF-I has hypertrophic effects on cultured myotubes [7] and skeletal muscle in rodents [8].
The purpose of this study was to further investigate the ability of
lengthening contractions to induce activation of known IGF-I-sensitive signaling proteins that are upstream of mTOR and proposed
to contribute to the regulation of mechanisms speciﬁc for mTOR
activation.
2. Materials and methods
2.1. Animals and genotyping
All procedures were approved by the University of Maryland
Animal Care and Use Committee. Adult (21-24 weeks) male
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wild-type (WT) and IGF receptor mutant (MKR) mice were utilized
in this study [9,10]. MKR mice possess a skeletal muscle speciﬁc
dominant-negative kinase-inactive IGF-I receptor. Mice were
maintained under a 12 h light-dark cycle with free access to a standard chow diet. All food was removed 4–5 h prior to testing.

attained to keep the integrated optical densities (IODs) within
the linear and non-saturated range. IODs were quantiﬁed using Image J software (NIH, Version 1.42).

2.2. Muscle stimulation protocol

The primary antibodies Ser473 – Akt, Akt, Thr389 –p70S6 kinase
(p70S6K, 1:500), p70S6K (1:500), Thr246 -PRAS40, PRAS40, Ser307 IRS-1, Ser636/639 -IRS-1, IRS-1 (1:500), PI3 Kinase p85 were
purchased from Cell Signaling Technologies Inc. (Beverly, MA).
All were used at 1:1000 unless indicated. Antibody speciﬁcity
was veriﬁed by molecular weight and positive controls where
possible.

Mice were anesthetized, weighed and placed prone onto a platform with the left hindlimb hanging freely over the side. The sciatic
nerve was stimulated posterior to the knee via subcutaneous needle electrodes (Harvard Apparatus 723742, Cambridge, MA). The
stimulating electrode was positioned proximal to the bifurcation
of the sciatic nerve, thus contractions occurred in all compartments of the leg. Proper electrode position was conﬁrmed by palpating the tibialis anterior (TA) during a series of 1 m twitches
and by observing plantarﬂexion at the ankle joint. This protocol
[11] elicits an overall effect of plantar ﬂexion due to the overriding
force of the gastrocnemius, soleus, and plantaris. The net result is a
lengthening contraction of the TA muscle, the primary dorisiﬂexor.
The right limb was not stimulated and used as an internal control
limb. Muscle contractions were elicited by stimulating the nerve at
100 Hz for 3 s followed by 10 s rest for 6 repetitions. Following the
6th repetition was a 30 s rest. The foot was returned passively to
the resting position at the end of each contraction in order to ensure plantarﬂexion was occurring throughout the protocol. The total protocol consisted of 10 sets for a total exercise time of 22 min
[11].
2.3. Muscle collection and processing
Mice were sacriﬁced either directly following (0 h) or 3 h after
the completion of the stimulation protocol. For the 3 h cohort, following the completion of the contraction protocol, the animals
were returned to their cage and after 3 h animals were anesthetized again for removal of the tissue. TA muscles were quickly
removed from anesthetized animals, blotted, weighed, and immediately frozen in liquid nitrogen. TA muscles were homogenized on
ice in buffer containing 50 mM HEPES (pH 7.4), 0.1% Triton X-100,
4 mM EGTA, 10 mM EDTA, 15 mM Na4P2O7H2O, 100 mM b-glycerophosphate, 25 mM NaF, protease inhibitor cocktail (Roche) and
5 mM Na3VO4 as previously described [12,13]. Protein concentration was determined by BCA protein assay (Pierce, Rockford, IL).
2.4. Immunoprecipitation
Five hundred micrograms of total protein was incubated with
insulin related substrate-1 (IRS-1) antibody (1:50) with gentle
rocking at 4 °C overnight. Protein A-Sepharose gel beads (Sigma)
were used to precipitate IRS-1 complexes by incubating the
washed beads with the IRS-1 complexes for 3 h at 4 °C. Samples
were centrifuged, re-suspended in loading buffer, boiled for
5 min and processed as described below.
2.5. SDS–PAGE, Western blotting, and immunodetection
Samples were solubilized in loading buffer and boiled for 5 min.
Hundred microgram of total protein was loaded into SDS–PAGE
gels and transferred onto PVDF membranes (Millipore, Billerica,
MA). To conﬁrm transfer of proteins and equal loading of lanes,
membranes were stained with Ponceau S. After successful transfer
of proteins, membranes were blocked for 1 h at room temperature
and incubated with primary antibody in dilution buffer (BSA in
TBS-T) overnight at 4 °C. Membranes were then incubated with a
secondary antibody, washed and then incubated with enhanced
chemiluminescence reagent (Pierce, Rockford, IL). Exposures were

2.6. Antibodies

2.7. Statistics
Data are means ± S.E.M. All protein analyses are expressed relative to the unstimulated (right) control limb from the WT animals.
T-tests were used to analyze differences between body and skeletal
muscle weight between WT and MKR mice. One way analysis of
variance with Dunnett’s post hoc tests was used to determine differences from the control. A P-value of <0.05 was considered statistically signiﬁcant.

3. Results
To determine if a functional IGF-I receptor is obligatory for the
activation of the Akt/mTOR signaling pathway, we utilized a transgenic mouse that expresses a mutated IGF-I receptor speciﬁcally in
skeletal muscle. Demonstration of the dysfunctional IGF-I and
insulin receptors in these mice via recombinant IGF-I and insulin
injections has been previously described [13].
Total body weight was not signiﬁcantly different between WT
and MKR age-matched mice for the 3 h time point (P > 0.05), however, body weight and TA weight were greater in the WT compared
to the MKR mice for the 0h time point (32.2 ± 0.6 g vs. 28.6 ± 1.1 g,
P < 0.05 and 0.051 ± 0.001 g vs. 0.035 ± 0.002 g, P < 0.05, respectively). In addition, at the 3 h time point, WT TA weight was significantly greater compared to the MKR mice (0.052 ± 0.005 g vs
0.039 ± 0.002 g, P < 0.05, respectively). These ﬁndings are similar
to previous reports showing slightly decreased muscle and body
weights in adult MKR mice [9,13].
Directly following the stimulation protocol (0 h), we observed a
small but signiﬁcant increase in p70S6k phosphorylation (Thr-389)
in the WT stimulated limb compared with the control limb. At 3 h
following the stimulation protocol, there was a robust increase in
p70S6k phosphorylation (Thr-389) in the WT stimulated limb compared with the control limb and a signiﬁcant increase in p70S6k
phosphorylation (Thr-389) in the stimulated TA from MKR (Fig.
1A and B).
Immunoprecipitation experiments were conducted to investigate contraction-induced activation of the hypothesized downstream components of the IGF-I signaling pathway. Despite
detection of insulin receptor substrate (IRS-1) in all of the conditions, there was no detectable co-immunoprecipitation of IRS-1
with p85 (regulatory subunit of PI3-K), and no IRS-1 phosphorylation at Ser-307 or Ser-636/639 (Fig. 2).
Increased Akt phosphorylation (Ser-437) was observed at 0 h in
the stimulated limb of MKR mice relative to the MKR control muscle. By 3 h this difference in Akt phosphorylation in the stimulated
limb of MKR mice was not apparent (Fig. 3A and B). Interestingly,
no changes in Akt phosphorylation were detected in WT mice with
the exercise protocol at either time point.
PRAS40 has been identiﬁed as a protein that inhibits downstream mTOR signaling [14]. Akt can alleviate the inhibition of
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Fig. 1. (A and B). Effects of an acute bout of stimulated muscle contractions in WT and MKR mice on p70S6k phosphorylation (Thr-389) immediately after (A) and 3 h following
(B) muscle contractions. Immediately following (0 h) muscle contractions, a signiﬁcant increase in p70S6k phosphorylation was observed in the exercised (Ex) tibialis anterior
(TA) compared to the contralateral control (Cont) TA of WT mice. Three hour following muscle contractions, signiﬁcant increases were observed in p70S6k phosphorylation in
the Ex TA of both WT and MKR mice. Data expressed as fold differences from unstimulated control limb. (* different from WT-Cont, # different from MKR-Cont, P < 0.05).

Fig. 2. IGF-I receptor signaling in WT and MKR mice with mechanical stimulation.
There were no differences in co-localization of p85 with IRS-1 for WT or MKR mice
in the Ex or Cont limb and no differences in the phosphorylation of IRS-1 (Ser-307,
Ser-636/639), despite activation of p70S6k. No quantiﬁcation is presented due to a
lack of detection of any activation of any of the targets. Data collected in samples
3 h following stimulated muscle contractions. (+) = refers to protein lysates from
parameterial adipose tissue in WT mice.

mTOR via phosphorylation of PRAS40 on Thr-246 [15]. Therefore,
we investigated PRAS40 phosphorylation (Thr-246) as a potential
contributor to mTOR signaling with acute muscle stimulation.
Phosphorylation of PRAS40 (Thr-246) was decreased in the WT
stimulated limb compared to control at 0 h. At 3 h there were no
differences between PRAS40 phosphorylation in WT exercise and
control limb (Fig. 4A and B). No changes in PRAS40 were observed
in MKR mice.
4. Discussion
Our primary ﬁnding is that one bout of high frequency muscle
contractions increased p70S6k phosphorylation without evidence
of activation of speciﬁc IGF-I-sensitive signaling proteins. In addi-

tion, we observed this result despite the presence or absence of a
functional IGF-I receptor.
Activation of p70S6k has been related to hypertrophy in cardiac
myocytes [16,17], and increases in protein synthesis in cultured
ﬁbroblasts [18]. In skeletal muscle, increased p70S6k phosphorylation occurs in rats following an exercise protocol identical to the
current study and is signiﬁcantly correlated to increases in muscle
mass [11]. Signiﬁcant increases in p70S6k phosphorylation have
also been shown after seven days of chronic loading via functional
overload with no differences in p70S6k phosphorylation between
WT and MKR mice [13]. In the present study, we demonstrated
that p70S6k phosphorylation occurs in WT and MKR mice with
acute exercise however, p70S6k phosphorylation was not observed
at 0 h in MKR mice and the increase in MKR mice was attenuated
compared with WT mice at 3 h. Therefore, the ability to increase
cellular signals that initiate protein synthesis is present in mice
without a functional IGF-I receptor, albeit the response was delayed and attenuated. It is not clear why the attenuation occurred,
but it is possible that it is a result of the known metabolic defects
that occur in the MKR. For example, the MKR mice exhibit elevations in resting blood glucose and serum free fatty acids [9]. The
animals also respond poorly to glucose challenges and are proposed to be a model of type 2 diabetes [9], thus it is possible that
reduced levels of p70s6k phosphorylation in response to the
mechanical load is a result of the metabolic dysfunction. Indeed,
recent ﬁndings indicate that contraction-induced p70s6k phosphorylation is attenuated in rodent models that develop obesity and/or
insulin resistance [19]. MKR mice exhibit elevations in circulating
free fatty acids and thus it is possible that the elevation in FFA
exposure is affecting mTOR signaling by altering substrate utilization. Nonetheless, contractions were still able to induce signiﬁcant
increases in p70s6k phosphorylation even when IGF-I signaling is
ablated in muscle.
Despite the presence or absence of a functional IGF-I receptor,
the acute stimulation protocol did not elicit activation of the
immediate signaling proteins downstream of the IGF-I receptor.
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Fig. 3. (A and B). Effects of an acute bout of stimulated muscle contractions in WT and MKR mice on Akt phosphorylation (Ser-473) immediately after (A) and 3 h following
(B) muscle contractions. Immediately following (0 h) muscle contractions, a signiﬁcant increase in Akt phosphorylation was observed in the exercised (Ex) tibialis anterior
(TA) of MKR mice only. No differences were observed 3 h following muscle contractions. Data expressed as fold differences from unstimulated control limb (WT Cont). ($
different from all groups, P < 0.05).

Fig. 4. (A and B). Effects of an acute bout of stimulated muscle contractions in WT and MKR mice on PRAS40 phosphorylation (Thr-246) immediately after (A) and 3 h
following (B) muscle contractions. Immediately following (0 h) muscle contractions, a signiﬁcant decrease in PRAS40 phosphorylation was observed in the exercised (Ex)
tibialis anterior (TA) of WT mice. No differences were observed 3 h following muscle contractions. Data expressed as fold differences from unstimulated control limb (WT
Cont). (* different from WT control, P < 0.05).

There is considerable controversy regarding the importance of
endogenous IGF-I for load-induced muscle hypertrophy [1]. Many
of the current hypotheses over the role of endogenous IGF-I are
based upon the ability of exogenous IGF-I to induce hypertrophy
[20]. Furthermore, exogenous IGF-I increases protein synthesis
and content in muscle through activation of PI3-K-Akt mediated
signaling [7]. Exposure of muscle cells to PI3K inhibitors, wortman-

nin or LY294002, prevents any effect of IGF-I on Akt signaling [21].
Thus, if IGF-I is critical for load-induced hypertrophy, we should
see evidence of PI3-K-Akt activation in response to mechanical
load. In order for PI3-K to be activated by IGF-I, it should functionally interact with IRS-1, however using immunoprecipitation, we
found no evidence of PI3-K interaction with IRS-1 in response to
load. This is in agreement with previous evidence, which indicated
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that inhibition of PI3-K did not prevent stretch-induced activation
of mTOR signaling [22]. We attempted to measure PLD1 phosphorylation at both time points and were unable to reliably detect any
PLD1 phosphorylation under any condition. It is possible that the
endogenous forms of phosphorylated PLD are expressed at such
low levels that it is difﬁcult to detect through standard Western
blotting applications (Troy Hornberger, Ph.D. personal communication). In addition, recent data suggest that PLD1 may be regulated through direct interaction with Rheb [23]. Thus, it is clear
that translation of mechanical load to mTOR signaling is complex
and remains undeﬁned.
Notably, we observed evidence of mTOR activation despite
either an inability to activate the IGF-I receptor or an indication
that IRS-1 is bound to the p85 subunit of PI3-K. Measuring Thr389 phosphorylation of p70s6k is the most reliable indicator of
mTOR activation in that mTOR activity does not appear to be regulated by alterations in phosphorylation status [1]. In addition,
IGF-I is a known activator of serine 307 phosphorylation of IRS-1
in muscle [24], yet we found no evidence of any serine phosphorylation of IRS-1 at any time point after stimulation. Together with
previous data showing that MKR exhibited a normal hypertrophic
response to chronic functional overload [13], this suggests that
activation IGF-I receptor signaling is not obligatory for load-induced activation of mTOR signaling. In fact, other groups have recently found evidence in humans that increases in exogenous in
IGF-I do not contribute to signiﬁcant increases in fractional protein
synthesis in skeletal muscle [25,26].
Proline-rich Akt substrate 40 (PRAS40) has been identiﬁed as a
target of Akt [27] that can modulate the activity of mTOR via mTOR
complex 1 (mTORC1). Sancak et al. showed that PRAS40 binds with
raptor and mTORC1 to suppress p70S6k phosphorylation, whereas
insulin-stimulated Akt-induced phosphorylation of PRAS40 (Thr246) released the inhibition of PRAS40 on mTORC1 to increase
p70S6k phosphorylation [15]. Surprisingly, we found a decrease in
PRAS40 phosphorylation (Thr-246) in the stimulated TA of WT
mice immediately following the protocol which corresponded to
an increase in p70S6k phosphorylation (Thr-389) indicating that
mechanical stimulation may involve a PRAS40 inﬂuence on mTOR
in manner that is different than seen with insulin. However, more
studies need to be conducted to conﬁrm or examine the role of
PRAS40 in load-induced hypertrophy in a more detailed fashion.
In summary, our results indicate that one session of high frequency muscle contractions in mice can activate cellular signaling
that initiates the protein synthesis independent of traditionally
described IGF-I signaling. Future studies are required to further elucidate the mechanisms by which cells sense and translate the various signals elicited by exercise stimuli into functional adaptations.
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